Safety and immunogenicity of inactivated Rift Valley Fever Smithburn viral vaccine in sheep

[1] Bird BH(2009)Rift Valley fever virus J Am Vet Med Assoc 234 883-893

[2] Flick R(2005)Rift Valley fever virus Curr Mol Med 5 827-834

[3] Bouloy M(2017)Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate Expert Rev Vaccines 16 601-611

[4] Ikegami T(1931)Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep cattle and man from East Africa J Pathol Bacteriol 34 545-579

[5] Daubney R(2010)Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention Vet Res 41 61-579

[6] Hudson J(2020)Rift Valley fever: important considerations for risk mitigation and future outbreaks Trop Med Infect Dis 5 89-41

[7] Garnham P(2017)Current status of Rift Valley fever vaccine development Vaccines 5 29-791

[8] Pepin M(2010)Rationalizing the development of live-attenuated virus vaccines Nat Biotechnol 28 573-15

[9] Grossi-Soyster EN(1991)Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep Vaccine 9 35-48

[10] LaBeaud AD(2006)Adverse response of non-indigenous cattle of European breeds to live-attenuated Smithburn Rift Valley fever vaccine J Med Virol 78 787-93

[1] Bird BH(2009)Rift Valley fever virus J Am Vet Med Assoc 234 883-893

[2] Flick R(2005)Rift Valley fever virus Curr Mol Med 5 827-834

[3] Bouloy M(2017)Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate Expert Rev Vaccines 16 601-611

[4] Ikegami T(1931)Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep cattle and man from East Africa J Pathol Bacteriol 34 545-579

[5] Daubney R(2010)Rift Valley fever virus (Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention Vet Res 41 61-579

[6] Hudson J(2020)Rift Valley fever: important considerations for risk mitigation and future outbreaks Trop Med Infect Dis 5 89-41

[7] Garnham P(2017)Current status of Rift Valley fever vaccine development Vaccines 5 29-791

[8] Pepin M(2010)Rationalizing the development of live-attenuated virus vaccines Nat Biotechnol 28 573-15

[9] Grossi-Soyster EN(1991)Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep Vaccine 9 35-48

[10] LaBeaud AD(2006)Adverse response of non-indigenous cattle of European breeds to live-attenuated Smithburn Rift Valley fever vaccine J Med Virol 78 787-93